Stephen Wallace, MD
Foot and Ankle Surgery · Denver, CONPI 1205222502
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (30.8%), education and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Arthrex at 57.0% of the total. Reporting peaked in 2020 at $10,000 and has fallen 59.3% since, to $4,075 in 2025. Among foot and ankle surgery clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $253.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$19K
- Pylant Medical$5K
- Extremity Medical$5K
- Stryker$1K
- Vilex LLC$1K
- Paragon 28, Inc.$369
- plus $1K from 14 others
What the payments were for
- Consulting fees$5,50017%
- Grants$10,00031%
- Travel & lodging$4,38213%
- Food & beverage$4,70414%
- Education$7,91924%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 56 | $18,531 |
| Pylant Medical | 19 | $5,231 |
| Extremity Medical | 6 | $4,757 |
| Stryker | 16 | $1,116 |
| Vilex LLC | 2 | $1,000 |
| Paragon 28, Inc. | 2 | $369 |
| Linvatec Corporation | 2 | $238 |
| Medical Device Business Services, Inc. | 3 | $230 |
| Johnson & Johnson | 7 | $229 |
| Restor3d, Inc. | 1 | $207 |
| Si-bone, Inc. | 1 | $126 |
| Next Science LLC | 1 | $90 |
| Bioventus LLC | 3 | $86 |
| Medline Industries LP | 2 | $74 |
| Orthalign Inc | 1 | $73 |
| Globus Medical | 1 | $43 |
| Smith+Nephew | 2 | $43 |
| Innovation Technologies Inc | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Axogen | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IO Freedom$3,000
- ARTEMIS Lapidus - R&D$500
- FUZE$500
- INFINITY$261
- Product Portfolio$238
- AXS INFINITY LS$166
- QUANTUM$150
- INBONE$136
- MONKEY RINGS$131
- AUGMENT INJECTABLE$122
- PROPHECY$115
- IO FiX$104
How this compares
$32,505 in reported general payments places this provider in the 90th percentile of 181 foot and ankle surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 41 | $548 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 48 | $484 |
| Hydroxyzine Hcl | 32 | $239 |
| Methylprednisolone | 15 | $105 |
| Meloxicam | 39 | $71 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Denver
- Kevin NagamaniDenver$288K
- Keith JacobsonDenver$241K
- Marissa JamiesonDenver$30K
- Matthew GorskiDenver$14K
- Eric JaakolaDenver$14K
- Olivera JovicDenver$10K
- Lauren MolchanDenver$10K
- Emma KayalDenver$8K
- Michael HoughtonFort Collins$2M
- Joshua MetzlEnglewood$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.